Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 610 of 745

Advanced search

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns

The Motley FoolOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns

Yahoo FinanceOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

NKGen Biotech to Present at the 2026 BIOCHINA Global Forum

GlobeNewswireOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Late-breaking ESC 2026 spot for Tenax (TENX) Phase 3 LEVEL trial data

Stock TitanOriginal source

🇨🇦Jul 2Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

NephroMax High Pressure Nephrostomy Balloon Catheter

Boston Scientific is notifying you that the renal sheath for certain NephroMax™ high pressure nephro...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 2Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

LIFECODES LSA Class II

Werfen has identified that two beads within the LIFECODES LSA class II assay kit(s) may present diff...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 2Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Glidesheath Slender® Introducer Sheath

Through post-market surveillance, we have received complaints for the guidewire not being able to pa...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 2Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Fludeoxyglucose (18F) Injection; Cracket vial

Fludeoxyglucose (18F) vial containing 24.80 mL (30.23 GBq of the product) used to administered the d...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Jul 2Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

AirSeal Access Port With Blunt Obturator and AirSeal Access Port With Optical Obturator

Complaint review identified a prior manufacturing process update that may cause erroneous overpressu...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech pitched its plant-based BPH drug to pharma partners at BIO 2026

Stock TitanOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines shows 82% response in pancreatic cancer combo trial

Stock TitanOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

GlobeNewswireOriginal source

🌍Jul 2Industryinvestors.vivani.comTier 1 · Company source

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani MedicalOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Pharmaceutical Technology

Pharmaceutical TechnologyOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Podcast: HLTH Europe and BIO key trends rundown

Pharmaceutical TechnologyOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Telix advances Phase 3 prostate trial after FDA alignment

grafa.comOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics to present Phase 3 trial results at ESC

Investing.comOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Kane Biotech Announces Results of Annual and Special Meeting of Shareholders

Yahoo Finance SingaporeOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

The Motley FoolOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Thermo Fisher to back Arcturus (NASDAQ: ARCT) ARCT-032 Phase 3 and manufacturing

Stock TitanOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

China AI drug-design deals swell as US scrutiny mounts

South China Morning PostOriginal source

🇺🇰Jul 2Regulatorygov.ukTier 1 · Regulatory source

Rare and Imported Pathogens Laboratory (RIPL): user manual

Information for clinicians and referring laboratories about the range of tests offered by the Rare a...

UK Health Security AgencyOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

VERAXA advances lead cancer drug toward manufacturing work with ATUM

Stock TitanOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Arcturus taps Thermo Fisher to make its cystic fibrosis therapy

Stock TitanOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Tenax to present LEVEL trial data at ESC Congress before August results

Stock TitanOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026

Yahoo Finance SingaporeOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis

Business WireOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

The Globe and MailOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

Yahoo FinanceOriginal source

🇪🇺Jul 2Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Initiatives to Accelerate the Translation of Research into Market-Ready Surgical Implantable Medical Devices by Strengthening Regulatory Science and Improved Regulatory Competencies Among Researchers

CORDISOriginal source

🇪🇺Jul 2Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: MEDIQ Index - Local Clinical AI assistant for Real-Time Patient Summarization and Query

CORDISOriginal source

🌍Jul 2Mediasaama.comTier 2 · Direct publisher

Agentic AI in Clinical Programming: Why Reasoning Wins

SaamaOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Analysis: 50% cut in Danish pharma production could cost 30,000 jobs

medwatch.comOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

FDA approved cannabis: Why Schedule 3 means operators must prepare for pharmaceutical-grade MMJ now

MJBizDailyOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Halfway into the year, biotech is booming

STATOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Adragos and Towa to Produce 1.5 Billion Tablets a Year

CHEManagerOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Subscribes Structured Deposit Product With Amount Of RMB330 MLN

TradingViewOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

ReutersOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

US launches security probe into five pharma giants doing clinical trials in China

medwatch.comOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Realistic Timelines for Pharma Manufacturing Reshoring

Pharmaceutical ExecutiveOriginal source

🇺🇰Jul 2Researchsphr.nihr.ac.ukTier 2 · Direct publisher

Beyond attendance: Listening to children and families about the mental health support needs of young people not in school

NIHR School for Public Health ResearchOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million

WSJOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Tracking Cathie Wood: Major Circle Accumulation and Biotech Cluster Build-Up, Trimming Alibaba and Medical Device

MoomooOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet

WSJOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up to $600 Million

WSJOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

New data strengthen cemdisiran case in generalized MG

The Pharma LetterOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Can-Fite to test namodenoson in pancreatic cancer

The Pharma LetterOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

China's CSPC Pharmaceutical Group to partner with AstraZeneca for renal disease drug

TradingViewOriginal source

🇺🇰Jul 2Regulatorygov.ukTier 1 · Regulatory source

Lord Mann review on antisemitism and other forms of racism in the NHS

An urgent review led by Lord John Mann examining how the NHS, including employers and UK health regu...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 2Regulatorygov.ukTier 1 · Regulatory source

Safeguarding UK human genomic data

Guidance setting clear expectations for how human genomic data is made available to approved users.

UK Department of Health and Social CareOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Glenmark initiates Phase 3 trial of $1 billion Cancer buyout Trastuzumab rezetecan

ETPharma.comOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

CSPC Pharmaceutical Enters Collaboration, Option & License Agreement With Astrazeneca For siRNA Drugs

TradingViewOriginal source

🇺🇰Jul 2Regulatorygov.ukTier 1 · Regulatory source

National norovirus and rotavirus surveillance reports: 2025 to 2026 season

Reports of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in hospital s...

UK Health Security AgencyOriginal source

🇺🇰Jul 2Regulatorygov.ukTier 1 · Regulatory source

Pre-release access lists: National norovirus and rotavirus surveillance reports

Lists of those receiving pre-release access to UK Health Security Agency national norovirus and rota...

UK Health Security AgencyOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

GC Biopharma starts Korea phase 3 for two-dose varicella vaccine - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

iA Global Asset Management Inc. Purchases 91,026 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

BII takes next step in its European expansion: Joins new Italy-focused venture fund

medwatch.comOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Top 10: Sustainable Pharmaceutical Companies

Sustainability MagazineOriginal source

🇯🇵Jul 2Industryono-pharma.comTier 1 · Company source

2027年3月期第1四半期決算発表

Ono Pharmaceutical NewsOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Glenmark Advances Multi-Country Phase 3 Trial of Trastuzumab rezetecan in Platinum-Resistant Ovarian Cancer

IndiaMedTodayOriginal source

Pharmaceutical industry news

SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns

SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns

NKGen Biotech to Present at the 2026 BIOCHINA Global Forum

Late-breaking ESC 2026 spot for Tenax (TENX) Phase 3 LEVEL trial data

NephroMax High Pressure Nephrostomy Balloon Catheter

LIFECODES LSA Class II

Glidesheath Slender® Introducer Sheath

Fludeoxyglucose (18F) Injection; Cracket vial

AirSeal Access Port With Blunt Obturator and AirSeal Access Port With Optical Obturator

Jyong Biotech pitched its plant-based BPH drug to pharma partners at BIO 2026

Revolution Medicines shows 82% response in pancreatic cancer combo trial

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Pharmaceutical Technology

Podcast: HLTH Europe and BIO key trends rundown

Telix advances Phase 3 prostate trial after FDA alignment

Tenax Therapeutics to present Phase 3 trial results at ESC

Kane Biotech Announces Results of Annual and Special Meeting of Shareholders

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

Thermo Fisher to back Arcturus (NASDAQ: ARCT) ARCT-032 Phase 3 and manufacturing

China AI drug-design deals swell as US scrutiny mounts

Rare and Imported Pathogens Laboratory (RIPL): user manual

VERAXA advances lead cancer drug toward manufacturing work with ATUM

Arcturus taps Thermo Fisher to make its cystic fibrosis therapy

Tenax to present LEVEL trial data at ESC Congress before August results

Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026

Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

CORDIS project: Initiatives to Accelerate the Translation of Research into Market-Ready Surgical Implantable Medical Devices by Strengthening Regulatory Science and Improved Regulatory Competencies Among Researchers

CORDIS project: MEDIQ Index - Local Clinical AI assistant for Real-Time Patient Summarization and Query

Agentic AI in Clinical Programming: Why Reasoning Wins

Analysis: 50% cut in Danish pharma production could cost 30,000 jobs

FDA approved cannabis: Why Schedule 3 means operators must prepare for pharmaceutical-grade MMJ now

Halfway into the year, biotech is booming

Adragos and Towa to Produce 1.5 Billion Tablets a Year

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Subscribes Structured Deposit Product With Amount Of RMB330 MLN

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

US launches security probe into five pharma giants doing clinical trials in China

Realistic Timelines for Pharma Manufacturing Reshoring

Beyond attendance: Listening to children and families about the mental health support needs of young people not in school

Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million

Tracking Cathie Wood: Major Circle Accumulation and Biotech Cluster Build-Up, Trimming Alibaba and Medical Device

Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet

Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up to $600 Million

New data strengthen cemdisiran case in generalized MG

Can-Fite to test namodenoson in pancreatic cancer

China's CSPC Pharmaceutical Group to partner with AstraZeneca for renal disease drug

Lord Mann review on antisemitism and other forms of racism in the NHS

Safeguarding UK human genomic data

Glenmark initiates Phase 3 trial of $1 billion Cancer buyout Trastuzumab rezetecan

CSPC Pharmaceutical Enters Collaboration, Option & License Agreement With Astrazeneca For siRNA Drugs

National norovirus and rotavirus surveillance reports: 2025 to 2026 season

Pre-release access lists: National norovirus and rotavirus surveillance reports

GC Biopharma starts Korea phase 3 for two-dose varicella vaccine - CHOSUNBIZ

iA Global Asset Management Inc. Purchases 91,026 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

BII takes next step in its European expansion: Joins new Italy-focused venture fund

Top 10: Sustainable Pharmaceutical Companies

2027年3月期 第1四半期決算発表

Glenmark Advances Multi-Country Phase 3 Trial of Trastuzumab rezetecan in Platinum-Resistant Ovarian Cancer

2027年3月期第1四半期決算発表